Glucocorticoids in the treatment of severe sepsis and septic shock
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Septic shock remains one of the leading causes of death in intensive care units. In recent years, there is general use of low to moderate doses of corticosteroids in the treatment of septic shock. However, there are wide variations in the practical modality of this treatment, mainly with regard to patients' selection, treatment's dose, timing, route of administration, duration, and weaning. This review provides opinion-based guidelines for the use of corticosteroids in severe sepsis and septic shock. RECENT FINDINGS: A summary of the latest understanding of the mechanisms of action of corticosteroids and the most recent observations in the clinical and biologic responses to corticosteroids in severe sepsis and septic shock is presented. SUMMARY: In septic shock, intravenous hydrocortisone should be started immediately after a 250 microg corticotropin test, at a dose of 200-300 mg per day. When adrenal insufficiency is confirmed, treatment should be continued at full doses for 7 days. Otherwise, hydrocortisone should be stopped. It is worth considering adding enteral fludrocortisone at a dose of 50 microg per day for 7 days. In severe sepsis, despite growing evidence to support the use of a moderate dose of corticosteroids, the efficacy and safety of this treatment needs to be assessed in a large-scale study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642 · cited 1×
“The latter does not bind glucocorticoids and inhibits glucocorticoids receptor-a (GRa) activity, possibly through formation of antagonistic GRa/GRb heterodimers [ 6 ].”
BackgroundKeh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-446oc · Cited by 600 · cited 2×
“In a randomized, double blind, crossover study [ 29 ], 40 patients with septic shock receive either the first 100 mg of hydrocortisone as a loading dose and 10 mg/h until day 3 (n =2 0) or placebo (n = 20), followed by the opposite medication until day 6. In this study, hydrocortisone infusion was associated with a dr…”
BackgroundMethodGlucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man
Barber, A. E., Coyle, S. M., Marano, M. A., Fischer, E., Calvano, S. E., Fong, Y., Moldawer, L. L., & Lowry, S. F. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1999 · Cited by 285
Cited by
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential
Becker, B. F., Chappell, D., Bruegger, D., Annecke, T., & Jacob, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq137 · Cited by 438
TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin
Chappell, D., Hofmann-Kiefer, K., Jacob, M., Rehm, M., Briegel, J., Welsch, U., Conzen, P., & Becker, B. F. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-008-0749-5 · Cited by 287
Sepsis-associated encephalopathy and its differential diagnosis
Iacobone, E., Bailly-Salin, J., Polito, A., Friedman, D., Stevens, R. D., & Sharshar, T. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b6ed58 · Cited by 266
Vasopressin, Epinephrine, and Corticosteroids for In-Hospital Cardiac Arrest
Mentzelopoulos, S. D., Zakynthinos, S. G., Tzoufi, M., Katsios, N., Papastylianou, A., Gkisioti, S., Stathopoulos, A., Kollintza, A., Stamataki, E., & Roussos, C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.509 · Cited by 257
Metadata
- Authors
- Annane, D.
- Venue
- Current Opinion in Critical Care
- Published
- 2005-10
- Volume
- 11
- Issue
- 5
- Pages
- 449-453
- ISSN
- 1070-5295 (ISSN-L)
- OpenAlex
- W2031857661
- Cited by
- 84
- References
- 4
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoids in the treatment of severe sepsis and septic shock. https://app.cochat.ai/papers/10.1097/01.ccx.0000176691.95562.43
- The paper
- Annane, D. (2005). Glucocorticoids in the treatment of severe sepsis and septic shock. Current Opinion in Critical Care. https://doi.org/10.1097/01.ccx.0000176691.95562.43
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.